Sources | Names Used |
---|---|
CTRPv2 | decitabine:navitoclax (2:1 mol/mol) |
PharmacoGx | decitabine:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TMSB15A | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-09 |
mRNA | AC138969.4 | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-09 |
mRNA | ELAVL1 | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-09 |
mRNA | RP11-15H20.8 | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-09 |
mRNA | ZKSCAN2 | CTRPv2 | pan-cancer | AAC | 0.2 | 7e-09 |
mRNA | ZNF266 | CTRPv2 | pan-cancer | AAC | 0.2 | 7e-09 |
mRNA | HMGB2 | CTRPv2 | pan-cancer | AAC | 0.22 | 7e-09 |
mRNA | SLC35E2 | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-09 |
mRNA | ELAVL3 | CTRPv2 | pan-cancer | AAC | 0.22 | 7e-09 |
mRNA | AC003006.7 | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-09 |